Epidemiology of heart failure and left ventricular dysfunction after acute myocardial infarction

被引:48
|
作者
Weir R.A.P. [1 ]
McMurray J.J.V. [1 ]
机构
[1] Department of Cardiology, Western Infirmary
关键词
Acute Myocardial Infarction; Acute Myocardial Infarction; Leave Ventricular Systolic Dysfunction; Acute Myocardial Infarction Patient; Dofetilide;
D O I
10.1007/s11897-006-0019-5
中图分类号
学科分类号
摘要
The development of heart failure and/or left ventricular systolic dysfunction has long been regarded as an ominous complication, significantly increasing the morbidity and short- and long-term mortality of survivors of acute myocardial infarction. Although the incidence of heart failure after myocardial infarction has fallen over the last few decades, it remains common, complicating up to 45% of infarcts. Moreover, up to 60% of myocardial infarcts will result in left ventricular systolic dysfunction, depending on the exact definition used. Those at greatest risk of developing heart failure are the elderly, females, and those with prior myocardial infarction. Advances in the management of acute myocardial infarction have led to reduced in-hospital mortality (even when complicated by heart failure), but longerterm mortality remains high in these patients. © Current Science Inc. 2006.
引用
收藏
页码:175 / 180
页数:5
相关论文
共 50 条
  • [1] Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: Prevalence, clinical characteristics, and prognostic importance
    Weir, Robin A. P.
    McMurray, John J. V.
    Velazquez, Eric J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (10A): : 13F - 25F
  • [2] Epidemiology and management of heart failure and left ventricular systolic dysfunction in the aftermath of a myocardial infarction
    Cleland, JGF
    Torabi, A
    Khan, NK
    HEART, 2005, 91 : 7 - 13
  • [3] Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction
    Bissessor, Naylin
    White, Harvey
    VASCULAR HEALTH AND RISK MANAGEMENT, 2007, 3 (04) : 425 - 430
  • [5] Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: The VALsartan In Acute myocardial iNfarcTion Trial (VALIANT)
    Shamshad, Faisal
    Kenchaiah, Satish
    Finn, Peter V.
    Soler-Soler, Jordi
    McMurray, John J. V.
    Velazquez, Eric J.
    Maggioni, Aldo P.
    Califf, Robert M.
    Swedberg, Karl
    Kober, Lars
    Belenkov, Yuri
    Varshavsky, Sergei
    Pfeffer, Marc A.
    Solomon, Scott D.
    AMERICAN HEART JOURNAL, 2010, 160 (01) : 145 - 151
  • [6] EplerenoneA Review of its Use in Left Ventricular Systolic Dysfunction and Heart Failure After Acute Myocardial Infarction
    Gillian M. Keating
    Greg L. Plosker
    Drugs, 2004, 64 : 2689 - 2707
  • [7] Eplerenone A review of its use in left ventricular systolic dysfunction and heart failure after acute myocardial infarction
    Keating, GM
    Plosker, GL
    DRUGS, 2004, 64 (23) : 2689 - 2707
  • [8] Contemporary epidemiology of left ventricular systolic dysfunction after myocardial infarction
    Torabi, A.
    Khan, N. K.
    Cleland, J. G. F.
    EUROPEAN JOURNAL OF HEART FAILURE, 2007, 6 : 75 - 75
  • [9] Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction
    Richards, AM
    Nicholis, MG
    Buttimore, RC
    Lainchbury, JG
    Frampton, C
    Ikram, H
    Espiner, EA
    Turner, JG
    Elliott, JM
    Crozier, IG
    Smyth, DW
    CIRCULATION, 1997, 96 (08) : 2182 - 2182
  • [10] Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction
    Richards, AM
    Nicholls, MG
    Yandle, TG
    Ikram, H
    Espiner, EA
    Turner, JG
    Buttimore, RC
    Lainchbury, JG
    Elliott, JM
    Frampton, C
    Crozier, IG
    Smyth, DW
    HEART, 1999, 81 (02) : 114 - 120